These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 15832623

  • 21. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
    Gupta P, Singh S, Goyal V, Shukla G, Behari M.
    Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
    [Abstract] [Full Text] [Related]

  • 22. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D, Ferraro D, Zelano G, Capuano A, Vollono C, Gabriele C, Di Trapani G.
    Clin Neuropharmacol; 2006 Mar; 29(5):269-75. PubMed ID: 16960472
    [Abstract] [Full Text] [Related]

  • 23. Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.
    Ergun H, Gulmez SE, Tulunay FC.
    Eur Neurol; 2007 Mar; 58(4):215-7. PubMed ID: 17827966
    [Abstract] [Full Text] [Related]

  • 24. Topiramate for migraine prophylaxis in pediatric patients.
    Deaton TL, Mauro LS.
    Ann Pharmacother; 2014 May; 48(5):638-43. PubMed ID: 24566461
    [Abstract] [Full Text] [Related]

  • 25. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW, Freitag F, Banks J, Saper J, Xiang J, Rupnow M, Biondi D, Greenberg SJ, Hulihan J, CAPSS-277 Investigator Group.
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [Abstract] [Full Text] [Related]

  • 26. Topiramate in migraine prevention: results of a large controlled trial.
    Silberstein SD, Neto W, Schmitt J, Jacobs D, MIGR-001 Study Group.
    Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
    [Abstract] [Full Text] [Related]

  • 27. Subcutaneous histamine versus topiramate in migraine prophylaxis: a double-blind study.
    Millán-Guerrero RO, Isais-Millán R, Barreto-Vizcaíno S, Gutiérrez I, Rivera-Castaño L, Trujillo-Hernández B, Baltazar LM.
    Eur Neurol; 2008 Apr; 59(5):237-42. PubMed ID: 18264012
    [Abstract] [Full Text] [Related]

  • 28. Acupuncture versus topiramate in chronic migraine prophylaxis: a randomized clinical trial.
    Yang CP, Chang MH, Liu PE, Li TC, Hsieh CL, Hwang KL, Chang HH.
    Cephalalgia; 2011 Nov; 31(15):1510-21. PubMed ID: 22019576
    [Abstract] [Full Text] [Related]

  • 29. Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials.
    Adelman J, Freitag FG, Lainez M, Shi Y, Ascher S, Mao L, Greenberg S, Hulihan J.
    Pain Med; 2008 Mar; 9(2):175-85. PubMed ID: 18298700
    [Abstract] [Full Text] [Related]

  • 30. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V, Biondi D, Pfeil J, Schwalen S.
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [Abstract] [Full Text] [Related]

  • 31. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials.
    Thienel U, Neto W, Schwabe SK, Vijapurkar U, Topiramate Diabetic Neuropathic Pain Study Group.
    Acta Neurol Scand; 2004 Oct; 110(4):221-31. PubMed ID: 15355485
    [Abstract] [Full Text] [Related]

  • 32. Comparison of efficacy and safety of topiramate with gabapentin in migraine prophylaxis: randomized open label control trial.
    Zain S, Khan M, Alam R, Zafar I, Ahmed S.
    J Pak Med Assoc; 2013 Jan; 63(1):3-7. PubMed ID: 23865122
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prevention of episodic migraine with topiramate: a prospective 24-week, open-label, flexible-dose clinical trial with optional 24 weeks follow-up in a community setting.
    Malessa R, Gendolla A, Steinberg B, Schmitt L, Bornhoevd K, Djelani M, Schäuble B, TOPMAT-MIG-3004 investigators.
    Curr Med Res Opin; 2010 May; 26(5):1119-29. PubMed ID: 20225996
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Effectiveness of topiramate in migraine prophylaxis, an observational study in a consecutive case-serie].
    Gracia-Naya M, Latorre Jiménez A.
    Neurologia; 2005 Jun; 20(5):225-31. PubMed ID: 15954031
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.